EP1263762A4 - Anti-infective ectatm - Google Patents

Anti-infective ectatm

Info

Publication number
EP1263762A4
EP1263762A4 EP01913190A EP01913190A EP1263762A4 EP 1263762 A4 EP1263762 A4 EP 1263762A4 EP 01913190 A EP01913190 A EP 01913190A EP 01913190 A EP01913190 A EP 01913190A EP 1263762 A4 EP1263762 A4 EP 1263762A4
Authority
EP
European Patent Office
Prior art keywords
ectatm
infective
infective ectatm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01913190A
Other languages
German (de)
French (fr)
Other versions
EP1263762A1 (en
Inventor
H Michael Shepard
Ming Fai Chan
Venkata Ramana Doppalapudi
Brian Edwin Cathers
Mark Stephen Hixon
Thomas J Lobl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celmed Oncology USA Inc
Original Assignee
Celmed Oncology USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celmed Oncology USA Inc filed Critical Celmed Oncology USA Inc
Publication of EP1263762A1 publication Critical patent/EP1263762A1/en
Publication of EP1263762A4 publication Critical patent/EP1263762A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
EP01913190A 2000-02-28 2001-02-27 Anti-infective ectatm Withdrawn EP1263762A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18547900P 2000-02-28 2000-02-28
US185479P 2000-02-28
PCT/US2001/006519 WO2001064687A1 (en) 2000-02-28 2001-02-27 Anti-infective ecta?tm¿

Publications (2)

Publication Number Publication Date
EP1263762A1 EP1263762A1 (en) 2002-12-11
EP1263762A4 true EP1263762A4 (en) 2003-04-02

Family

ID=22681148

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01913190A Withdrawn EP1263762A4 (en) 2000-02-28 2001-02-27 Anti-infective ectatm

Country Status (9)

Country Link
EP (1) EP1263762A4 (en)
JP (1) JP2003525298A (en)
CN (1) CN1419560A (en)
AU (1) AU2001241878A1 (en)
BR (1) BR0108758A (en)
CA (1) CA2401151A1 (en)
IL (1) IL151502A0 (en)
MX (1) MXPA02008368A (en)
WO (1) WO2001064687A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703374B1 (en) 1997-10-30 2004-03-09 The United States Of America As Represented By The Department Of Health And Human Services Nucleosides for imaging and treatment applications
WO2002007780A2 (en) * 2000-07-20 2002-01-31 Newbiotics, Inc. Methods for identifying therapeutic targets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348264A (en) * 1980-05-14 1982-09-07 Pfizer Inc. Photocatalyzed process for producing carbapenams and carbapen-2-ems
RO88451A2 (en) * 1984-06-05 1986-01-30 Intreprinderea De Antibiotice,Ro 7-AMINOCEPHALOSPORANIC ACID DERIVATIVES AND PROCESS FOR PREPARING THE SAME

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
IL151502A0 (en) 2003-04-10
EP1263762A1 (en) 2002-12-11
BR0108758A (en) 2003-03-18
JP2003525298A (en) 2003-08-26
MXPA02008368A (en) 2002-12-13
CN1419560A (en) 2003-05-21
CA2401151A1 (en) 2001-09-07
WO2001064687A1 (en) 2001-09-07
AU2001241878A1 (en) 2001-09-12

Similar Documents

Publication Publication Date Title
DE60105852D1 (en) Fluidmischsystem
DE50112082D1 (en) Bulk-acoustic-wave-filter
GB2364651B (en) Golf-putters
DE60115644D1 (en) Thiazinoxazolidinon
AU3391801A (en) Pyridinylimidazoles
AU8274301A (en) Electro-powder
DE50104081D1 (en) Hydrolager
DE50105205D1 (en) Creatinin-biosensor
DE60114954D1 (en) Polytrimethylenterephthalatgarn
AU6803901A (en) Bis-arylsulfones
DE50112740D1 (en) Strangführungselement
DE60120222D1 (en) Laser-anemometer
DE50110569D1 (en) Substituierte c-cyclohexylmethylamin-derivate
DE50107376D1 (en) Orientierte acrylathotmelts
DE50112014D1 (en) Stiftheizer
DE50102859D1 (en) Hochfliessfähige propylenblockcopolymerisate
AU9385201A (en) Sulfonylguanidine
DE50107703D1 (en) Creatininsensor-kalibration
DE50008626D1 (en) Substituierte aminomethyl-phenyl-cyclohexanderivate
AU6619001A (en) Liquid-pourers
DE50008447D1 (en) Aminomethyl-phenyl-cyclohexanonderivate
DE50114303D1 (en) Nsaugluftkanal
AU9187601A (en) Triazolo-epothilones
AU4686401A (en) Hypotensors
DE50100877D1 (en) Thermoverformbares verbundmaterial

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020926

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NEWBIOTICS, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20030214

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20021001